Description

Diaglizid MR (gliclazide) Tablets with Prolonged Release 60 mg. №30

Ingredients:

Each tablet contains 60 mg of gliclazide.

Dosage:

The recommended dosage is one tablet daily, preferably taken with breakfast.

Indications:

Diaglizid MR tablets are indicated for the treatment of type 2 diabetes mellitus. It helps control blood sugar levels and reduce the risk of complications associated with diabetes.

Contraindications:

Do not use Diaglizid MR if you have a history of hypersensitivity to gliclazide or sulfonylureas, or if you have type 1 diabetes.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. It is important to follow your healthcare provider’s instructions while taking this medication.

Scientific Evidence:

Gliclazide, the active ingredient in Diaglizid MR, is a sulfonylurea that works by stimulating insulin release from the pancreas, thereby reducing blood sugar levels. Studies have shown that gliclazide effectively lowers HbA1c levels, indicating better long-term glucose control in patients with type 2 diabetes.

Research published in the Journal of Diabetes Investigation demonstrated that gliclazide with prolonged release formulations, like Diaglizid MR, not only effectively controls blood glucose levels but also reduces the risk of hypoglycemia compared to other sulfonylureas.

Additional Information:

• Storage: Store Diaglizid MR tablets in a cool, dry place away from direct sunlight.
• Side Effects: Common side effects may include hypoglycemia, weight gain, and gastrointestinal disturbances.
• Precautions: Regular monitoring of blood glucose levels is essential while taking Diaglizid MR to adjust the dosage as needed.